Comparison between Agilus Diagnostics IPO and Tea Post IPO.
Agilus Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tea Post IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Agilus Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the Tea Post IPO is up to ₹0.00 Cr. The final issue price of Agilus Diagnostics IPO is and of Tea Post IPO is .
| Agilus Diagnostics IPO | Tea Post IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 1,42,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,42,33,964 shares | 1,42,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,42,33,964 shares | 2,85,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Agilus Diagnostics IPO opens on , while Tea Post IPO opens on . The closing date of Agilus Diagnostics IPO and Tea Post IPO is , and , respectively.
Agilus Diagnostics IPO P/E ratio is , as compared to Tea Post IPO P/E ratio of .
| Agilus Diagnostics IPO | Tea Post IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.68 | 37.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.12% | -10.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.17% | 13.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-0.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.61% | -10.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Agilus Diagnostics IPO Retail Individual Investors (RII) are offered while in Tea Post IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Agilus Diagnostics IPO and in Tea Post IPO.
Agilus Diagnostics IPO subscribed in total, whereas Tea Post IPO subscribed .
| Agilus Diagnostics IPO | Tea Post IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
